|
|
 |
TACLONEX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VANILLIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SYMDEKO (COPACKAGED) Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
SYMBICORT Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
TAFINLAR Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
TITANIUM DIOXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
UREA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|